Elora

New study results for eloralintide, an injectable weight-loss drug developed by Eli Lilly, are drawing attention alongside Mounjaro. The Guardian describes the drug as a potential 'Godzilla' of weight-loss treatments, suggesting it could deliver weight reduction plus other important health benefits. Discussion is focused on how it might compete with existing GLP-1 drugs like Mounjaro and what additional health effects it may offer.

CITGO has recognized Elora as a Distinguished Scholar in the Career & Technical Education category, according to ABC13 Houston's scholar profile series. The program highlights high-achieving students in the Houston area, with CITGO backing awards across different academic and technical fields. Beyond the recognition itself, no further details about Elora's school or achievements were given.